Successful treatment of dopamine dysregulation syndrome with dopamine D 2 partial agonist antipsychotic drug

Jin Mizushima, Keisuke Takahata, Noriko Kawashima, Motoichiro Kato

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Dopamine dysregulation syndrome (DDS) consists of a series of complications such as compulsive use of dopaminergic medications, aggressive or hypomanic behaviors during excessive use, and withdrawal states characterized by dysphoria and anxiety, caused by long-term dopaminergic treatment in patients with Parkinson's disease (PD). Although several ways to manage DDS have been suggested, there has been no established treatment that can manage DDS without deterioration of motor symptoms. In this article, we present a case of PD in whom the administration of the dopamine D 2 partial agonistic antipsychotic drug aripiprazole improved DDS symptoms such as craving and compulsive behavior without worsening of motor symptoms. Considering the profile of this drug as a partial agonist at D 2 receptors, it is possible that it exerts its therapeutic effect on DDS by modulating the dysfunctional dopamine system.

Original languageEnglish
Article number19
JournalAnnals of General Psychiatry
Volume11
DOIs
Publication statusPublished - 2012 Jul 7

Fingerprint

Antipsychotic Agents
Dopamine
Therapeutics
Parkinson Disease
Compulsive Behavior
Therapeutic Uses
Anxiety
Pharmaceutical Preparations

Keywords

  • Aripiprazole
  • Dopamine d2 partial agonistic antipsychotic drug
  • Dopamine dysregulation syndrome (dds)
  • Dopamine replacement therapy (drt)
  • Parkinson's disease

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Successful treatment of dopamine dysregulation syndrome with dopamine D 2 partial agonist antipsychotic drug. / Mizushima, Jin; Takahata, Keisuke; Kawashima, Noriko; Kato, Motoichiro.

In: Annals of General Psychiatry, Vol. 11, 19, 07.07.2012.

Research output: Contribution to journalArticle

Mizushima, Jin ; Takahata, Keisuke ; Kawashima, Noriko ; Kato, Motoichiro. / Successful treatment of dopamine dysregulation syndrome with dopamine D 2 partial agonist antipsychotic drug. In: Annals of General Psychiatry. 2012 ; Vol. 11.
@article{367601d1599d4cbf8927e7bbcd5af502,
title = "Successful treatment of dopamine dysregulation syndrome with dopamine D 2 partial agonist antipsychotic drug",
abstract = "Dopamine dysregulation syndrome (DDS) consists of a series of complications such as compulsive use of dopaminergic medications, aggressive or hypomanic behaviors during excessive use, and withdrawal states characterized by dysphoria and anxiety, caused by long-term dopaminergic treatment in patients with Parkinson's disease (PD). Although several ways to manage DDS have been suggested, there has been no established treatment that can manage DDS without deterioration of motor symptoms. In this article, we present a case of PD in whom the administration of the dopamine D 2 partial agonistic antipsychotic drug aripiprazole improved DDS symptoms such as craving and compulsive behavior without worsening of motor symptoms. Considering the profile of this drug as a partial agonist at D 2 receptors, it is possible that it exerts its therapeutic effect on DDS by modulating the dysfunctional dopamine system.",
keywords = "Aripiprazole, Dopamine d2 partial agonistic antipsychotic drug, Dopamine dysregulation syndrome (dds), Dopamine replacement therapy (drt), Parkinson's disease",
author = "Jin Mizushima and Keisuke Takahata and Noriko Kawashima and Motoichiro Kato",
year = "2012",
month = "7",
day = "7",
doi = "10.1186/1744-859X-11-19",
language = "English",
volume = "11",
journal = "Annals of General Psychiatry",
issn = "1744-859X",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Successful treatment of dopamine dysregulation syndrome with dopamine D 2 partial agonist antipsychotic drug

AU - Mizushima, Jin

AU - Takahata, Keisuke

AU - Kawashima, Noriko

AU - Kato, Motoichiro

PY - 2012/7/7

Y1 - 2012/7/7

N2 - Dopamine dysregulation syndrome (DDS) consists of a series of complications such as compulsive use of dopaminergic medications, aggressive or hypomanic behaviors during excessive use, and withdrawal states characterized by dysphoria and anxiety, caused by long-term dopaminergic treatment in patients with Parkinson's disease (PD). Although several ways to manage DDS have been suggested, there has been no established treatment that can manage DDS without deterioration of motor symptoms. In this article, we present a case of PD in whom the administration of the dopamine D 2 partial agonistic antipsychotic drug aripiprazole improved DDS symptoms such as craving and compulsive behavior without worsening of motor symptoms. Considering the profile of this drug as a partial agonist at D 2 receptors, it is possible that it exerts its therapeutic effect on DDS by modulating the dysfunctional dopamine system.

AB - Dopamine dysregulation syndrome (DDS) consists of a series of complications such as compulsive use of dopaminergic medications, aggressive or hypomanic behaviors during excessive use, and withdrawal states characterized by dysphoria and anxiety, caused by long-term dopaminergic treatment in patients with Parkinson's disease (PD). Although several ways to manage DDS have been suggested, there has been no established treatment that can manage DDS without deterioration of motor symptoms. In this article, we present a case of PD in whom the administration of the dopamine D 2 partial agonistic antipsychotic drug aripiprazole improved DDS symptoms such as craving and compulsive behavior without worsening of motor symptoms. Considering the profile of this drug as a partial agonist at D 2 receptors, it is possible that it exerts its therapeutic effect on DDS by modulating the dysfunctional dopamine system.

KW - Aripiprazole

KW - Dopamine d2 partial agonistic antipsychotic drug

KW - Dopamine dysregulation syndrome (dds)

KW - Dopamine replacement therapy (drt)

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84864336526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864336526&partnerID=8YFLogxK

U2 - 10.1186/1744-859X-11-19

DO - 10.1186/1744-859X-11-19

M3 - Article

VL - 11

JO - Annals of General Psychiatry

JF - Annals of General Psychiatry

SN - 1744-859X

M1 - 19

ER -